No Detail Found!

COVID-19 vaccines interim analysis: Unanswered questions

Author(s)
Rehama Ahsan Gilani Department of Public Health, National University of Medical Sciences, Rawalpindi, Pakistan
Abstract
It will be one year since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has created havoc and mayhem in form of coronavirus disease 2019 (COVID-19) pandemic. Many potential vaccines candidates are identified and are currently in different phases of clinical trial. The international regulatory authority has given emergency approval of two vaccines, Pfizer and BioNTech and Moderna. The Phase 3 trial of both these vaccines are still in progress and there are scattered reports of adverse effects including allergic reaction among vaccinated health care workers. The safety profile of these vaccines requires long term follow up of patients before one can assure its efficacy and clinical effectiveness.
Publication Details
Page(s) 133-134
Published Journal: Life and Science, Volume: 1, Issue: SI, Year: 2020

Request the full text from PASTIC

Keywords
COVID-19, COVID-19, COVID-19, SARS-CoV-2, Covid-19, Vaccines
0

Citations

0

Downloads

55

Views